Abbott weathered the enormous challenges of 2020 with a unique diversified business structure and continuous investment in innovation.
“In normal times, [our business structure] maximizes our growth opportunities, and during the pandemic, it has been tested by a global crisis and proven to be highly resilient,” CEO Robert Ford said during
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?